SEC Form 3 · accession 0001493152-26-042909
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
KI Holdings, Ltd.
10% Owner
Period of report
Aug 3, 2026
Accepted (ET)
Sep 16, 2026 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 10,000,000 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantsF1 | $0.06 | holding | — | — | — | Aug 3, 2026 | Aug 3, 2031 | Common Stock | 10,000,000 | — | D |
Explanation of responses
- F1KI Holdings Ltd. is 100% owned by Kivowitz Investments, Inc. which is owned by Donald Kivowitz